Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism TNFR1 inhibitors(Tumor necrosis factor receptor superfamily member 1A inhibitors), TNFR2 antagonists(Tumor necrosis factor receptor superfamily member 1B antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | KR | 13 Jun 2024 |